Arca
Skip to content
Tools
Tools

CALCR, RAMP3: Amylin receptor AMY3; CALCR/RAMP3

Complex in Homo sapiens that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on CALCR, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 1

Approved1

  • Pramlintide

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        PramlintideBoxed warningApprovedAstraZeneca PharmaceuticalsProtein or peptideAgonistAmylin receptor AMY3; CALCR/RAMP3 agonist6

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 6 in all, from ClinicalTrials.gov.
        Outpatient Pramlintide StudyPramlintideNot applicableNot yet recruitingOregon Health and Science UniversityNov 3, 2026
        Postprandial Regulation of Bone Perfusion in Healthy IndividualsPramlintideNot applicableNot yet recruitingUniversity of CopenhagenJul 1, 2026
        Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy HumansPramlintideNot applicableRecruitingUniversity Hospital, Gentofte, CopenhagenApr 1, 2026
        Hypersensitivity to Amylin in Post-Traumatic HeadachePramlintideNot applicableRecruitingDanish Headache CenterJan 14, 2026
        Amylin-Induced Migraine Attacks Without AuraPramlintideNot applicableNot yet recruitingDanish Headache CenterJan 14, 2026
        Multi-Center Development of a Novel Diagnostic Test for Alzheimer's DiseasePramlintideEarly phase 1Active, not recruitingBoston UniversityJun 19, 2018

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2111190, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.